Cargando…

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review

SIMPLE SUMMARY: Despite rapid advances in the development of novel agents over the last decade for the treatment of multiple myeloma (MM), MM remains an incurable disease. Therefore, the development of novel targeting therapies with different mechanisms of action is needed to achieve a deep and dura...

Descripción completa

Detalles Bibliográficos
Autor principal: Nishida, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198014/
https://www.ncbi.nlm.nih.gov/pubmed/34072645
http://dx.doi.org/10.3390/cancers13112712